CSIMarket


Iqvia Holdings Inc   (IQV)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Iqvia Holdings Inc

IQV's Fundamental analysis








Looking into Iqvia Holdings Inc growth rates, revenue grew by 2.33 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1478

Medical Laboratories industry recorded growth of revenues by 2.68 %

Iqvia Holdings Inc 's net profit deacreased by -0.35 % in I. Quarter 2024 year on year, to $288 millions.

More on IQV's Growth


Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Iqvia Holdings Inc PEG ratio is at 0.91 Iqvia Holdings Inc realized cash outflow of $ -0.27per share in trailing twelve-month period.
Company
28.92
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.6.
Medical Laboratories industry's Price to Sales ratio is at 2.93.


More on IQV's Valuation
 
 Total Debt (Millions $) 13,536
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 190,747
 Net Income/Employee (TTM) $ 17,177
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -69.98

Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Iqvia Holdings Inc PEG ratio is at 0.91 Iqvia Holdings Inc realized cash outflow of $ -0.27per share in trailing twelve-month period.
Company
28.92
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.6.
Medical Laboratories industry's Price to Sales ratio is at 2.93.

Iqvia Holdings Inc Price to Book Ratio is at 6.18 lower than Indusry Avg. of 418.78. and higher than S&P 500 Avg. of 0.01

More on IQV's Valuation

  Market Capitalization (Millions $) 39,210
  Shares Outstanding (Millions) 184
  Employees 79,000
  Revenues (TTM) (Millions $) 15,069
  Net Income (TTM) (Millions $) 1,357
  Cash Flow (TTM) (Millions $) -50
  Capital Exp. (TTM) (Millions $) -630
  Total Debt (Millions $) 13,536
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 190,747
  Net Income/Employee(TTM) $ 17,177
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -69.98

  Market Capitalization (Millions $) 39,210
  Shares Outstanding (Millions) 184
  Employees 79,000
  Revenues (TTM) (Millions $) 15,069
  Net Income (TTM) (Millions $) 1,357
  Cash Flow (TTM) (Millions $) -50
  Capital Exp. (TTM) (Millions $) -630


    IQV's Profitability Comparisons
Iqvia Holdings Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 13.54 % from 12.95 % in IV. Quarter.

Iqvia Holdings Inc net profit margin of 7.71 % is currently ranking no. 7 in Medical Laboratories industry, ranking no. 89 in Healthcare sector and number 1241 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.25
  Total Debt to Equity (MRQ) 2.13
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.57
  Inventory Turnover Ratio (TTM) -



Iqvia Holdings Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 13.54 % from 12.95 % in IV. Quarter.

Iqvia Holdings Inc net profit margin of 7.71 % is currently ranking no. 7 in Medical Laboratories industry, ranking no. 89 in Healthcare sector and number 1241 in S&P 500.

More on IQV's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com